Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children ; volume:10 ; number:1 ; day:3 ; month:11 ; year:2017 ; pages:1-10 ; date:12.2017
BMC Research Notes / Biomed Central; 10, Heft 1 (3.11.2017), 1-10, 12.2017
- Creator
-
Hassan, Joanne
- Contributor
-
Wangai, Laura
Borus, Peter
Khayeka–Wandabwa, Christopher
Karani, Lucy Wanja
Kithinji, Mercy
Kiptoo, Michael
SpringerLink (Online service)
- DOI
-
10.1186/s13104-017-2843-y
- URN
-
urn:nbn:de:101:1-2018090514332832485743
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hassan, Joanne
- Wangai, Laura
- Borus, Peter
- Khayeka–Wandabwa, Christopher
- Karani, Lucy Wanja
- Kithinji, Mercy
- Kiptoo, Michael
- SpringerLink (Online service)
Other Objects (12)
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Vaccine as a Sociocultural Artefact: The Example of Locally Produced Polio Vaccine in Serbia
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Vaccine as a Sociocultural Artefact: The Example of Locally Produced Polio Vaccine in Serbia
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Vaccine as a Sociocultural Artefact: The Example of Locally Produced Polio Vaccine in Serbia